Does high-throughput screening against thioredoxin glutathione reductase identify novel inhibitors with potential therapeutic value for schistosomiasis?
These confirmed hits may serve as starting points for the development of novel therapeutics to combat schistosomiasis.
Our novel findings reveal that omentin-1 is downregulated by insulin and glucose. These may, in part, explain the decreased omentin-1 levels observed in our overweight women with PCOS.